0001127602-18-003852.txt : 20180202 0001127602-18-003852.hdr.sgml : 20180202 20180202180720 ACCESSION NUMBER: 0001127602-18-003852 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180202 FILED AS OF DATE: 20180202 DATE AS OF CHANGE: 20180202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cooke Shane CENTRAL INDEX KEY: 0001524823 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 18572206 MAIL ADDRESS: STREET 1: TREASURY BUILDING LOWER GRAND CANAL ST. CITY: DUBLIN 2 STATE: L2 ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-02-02 0001520262 Alkermes plc. ALKS 0001524823 Cooke Shane CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 IRELAND 1 President, Alkermes plc Ordinary Shares 2018-02-02 4 M 0 72793 16.55 A 147501 D Ordinary Shares 2018-02-02 4 S 0 53289 60.3762 D 94212 D Ordinary Shares 2018-02-02 4 S 0 19504 61.0281 D 74708 D Employee Stock Option (Right to Buy) 16.55 2018-02-02 4 M 0 72793 0 D 2022-05-21 Ordinary Shares 72793 50000 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/19/17. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.00 to $61.36. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. These options are fully vested in accordance with their terms. /s/ Jennifer Baptiste, attorney-in-fact for Shane Cooke 2018-02-02